Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Other Operating Expenses (2020 - 2025)

PAVmed has reported Other Operating Expenses over the past 5 years, most recently at $334000.0 for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 64.53% year-over-year to $334000.0; the TTM value through Dec 2025 reached $1.1 million, down 91.03%, while the annual FY2025 figure was $1.1 million, 93.33% down from the prior year.
  • Other Operating Expenses for Q4 2025 was $334000.0 at PAVmed, up from $256000.0 in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $7.9 million in Q4 2022 and troughed at -$17.1 million in Q1 2022.
  • A 5-year average of $1.0 million and a median of $1.4 million in 2021 define the central range for Other Operating Expenses.
  • Biggest five-year swings in Other Operating Expenses: soared 542.7% in 2024 and later tumbled 95.66% in 2025.
  • Year by year, Other Operating Expenses stood at $3.9 million in 2021, then soared by 101.92% to $7.9 million in 2022, then crashed by 87.31% to $1.0 million in 2023, then crashed by 79.7% to $203000.0 in 2024, then surged by 64.53% to $334000.0 in 2025.
  • Business Quant data shows Other Operating Expenses for PAVM at $334000.0 in Q4 2025, $256000.0 in Q3 2025, and $261000.0 in Q2 2025.